2023, Number 1
<< Back
Rev ADM 2023; 80 (1)
Placement of implants in a patient with a history of bisphosphonates taken.
Treviño RA, Rodríguez BA
Language: Spanish
References: 11
Page: 52-56
PDF size: 408.19 Kb.
ABSTRACT
The use of bisphosphonates is an excellent treatment for patients with rheumatoid arthritis and bone diseases such as osteoporosis. Here is a case report of a female patient, who was under consumption of this drug by prescription of her doctor for the prevention of post-menopausal rheumatoid arthritis. The patient went to the consultation for the placement of implants in the edentulous area and comments having finished the bisphosphonate treatment one year ago. The diagnostic tests were taken, and the implant placement was performed well without any complications. The control appointments were more frequent in four months, especially due to the detail of bisphosphonate consumption, but in no appointment, there were any alarming details, the healing was in good shape. The patient discharged after her regular appointments and to ensure that she was healing well and that implant was well placed.
REFERENCES
Daly C. Osteoporosis treatment and medication-related osteonecrosis of the jaws. Aust Prescr. 2016; 39 (2): 47-48.
Goodday RH. Preventive strategies for patients at risk of medication-related osteonecrosis of the jaw. Oral Maxillofac Surg Clin North Am. 2015; 27 (4): 527-536.
Fliefel R, Tröltzsch M, Kühnisch J, Ehrenfeld M, Otto S. Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg. 2015; 44 (5): 568-585.
Lorz Ulloa P, Varela Guillén R. La prueba CTX como evaluador de riesgo en el diagnóstico y tratamiento de osteonecrosis de los maxilares inducida por el uso de bifosfonatos. Odovtos - Int J Dent Sci. 2015; 17 (1): 41-51.
Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014; 72 (10): 1938-1956.
L, Dima; Watts, N(2014) "Bisphosphonate drug holiday: who, when and how long" 5(3) 107-111.
Fleisher, K; Kontio, R (2016) "Antiresorptive Drug-related Osteonecrosis Of The Jaw (ARONJ) –a guide to research" AOCMF
Svemoneli (2016) "Que son los bifosfonatos" Recuperado el 27 de Enero de 2021 de: https://www.svemonline.org/wp-content/uploads/2016/04/pacientes-osteoporosis-bifosfonato-jose-luque.pdf
Javelot, M; Sergheraet, J (2016) "Rituximab as a tigger factor of medication-related osteonecrosis of the jaw. A case report" JORMAS 718 pag. 1-5.
Pacheco, E (2019) "Colocación de implantes dentales en pacientes con antecedentes de calcio" 1(3) 1-10.
Rivas, C; Cedillo, V (2017) "Protocolo clínico de pacientes con historia de uso de bifosfonatos" Revista ADM, 74 (5) 252-260.
Full text
10.35366/109729